Asset Details
Do you wish to reserve the book?
Evaluation of botulinum toxin type A for treating post burn hypertrophic scars and keloid in children: An intra‐patient randomized controlled study
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Evaluation of botulinum toxin type A for treating post burn hypertrophic scars and keloid in children: An intra‐patient randomized controlled study
Do you wish to request the book?
Evaluation of botulinum toxin type A for treating post burn hypertrophic scars and keloid in children: An intra‐patient randomized controlled study
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Evaluation of botulinum toxin type A for treating post burn hypertrophic scars and keloid in children: An intra‐patient randomized controlled study
2023
Overview
Background Consequently, the management of post burn hypertrophic scars and keloid in children are a great challenge for the physicians, parents, and children themselves. Purpose of the Study To assess the efficacy and safety of treating hypertrophic and keloid scars with botulinum toxins injections. Patients and Methods This is a randomized intra‐patient comparative study was conducted on 15 children with post burn hypertrophic and keloid scars. Children were randomized to receive Intralesional injection of botulinum toxins on one part of the hypertrophic scar/keloid where the other part was left as a control. The assessment of clinical improvement was measured by the Vancouver scar scale (VSS) and by skin analysis camera system. Sessions were performed every month for 6 months. Results Clinical and statistical dramatic improvement in the vascularity, pliability, and height of the lesions which have been injected with neuronox. Evaluation of the lesions by the Antera camera has proven marked changes in the vascularity and height. There was no correlations between Vancouver score improvement and variables such as the age, sex, skin type, and duration and lesion type. Conclusions The botulinum toxins proved its efficacy and safety in treatment of hypertrophic scars and keloid in children. It improved the associated itching and pain. Moreover it improves the pliability, erythema, and thickness of the scars.
Publisher
John Wiley & Sons, Inc
